Navigation Links
Cardiovascular issues up mortality rates in patients with advanced fibrosis
Date:4/10/2013

New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes. NAFLD alone was not associated with increased mortality according to findings published in the April issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

With super-sized portions, sugary soft drinks and physical inactivity, obesity is on the rise and showing no sign of slowing. Studies report that the prevalence of obesity has doubled in the U.S. over the past 25 years. As obesity rates have soared, so has the incidence of NAFLD, making it the most prevalent liver disease in the U.S.

NAFLD is a chronic form of liver disease that includes such conditions as steatosis without fibrosis, nonalcoholic steatohepatitis (NASH) with fibrosis, and cirrhosis. Fibrosis is the progressive scarring of the liver with stages ranging from zero to four (cirrhosis). Medical evidence has found that patients with simple steatosis have a better prognosis than those with NASH, which could progress to end-stage liver disease.

Lead investigator Dr. W. Kim Ray from the Mayo Clinic in Rochester, Minn. explains, "The effect of NAFLD on public health is not well understood. Large, population-based studies, which can provide insight into disease activity, present some difficulty given that liver biopsy is required to confirm NAFLD."

To investigate the long-term impact of NAFLD on mortality, the team used data from the National Health and Nutrition Examination Survey (NHANES)a survey by the National Center for Health Statistics in conjunction with the Centers for Disease Control and Prevention (CDC) that was conducted from 1988 to 1994 with mortality follow-up through 2006. NAFLD was diagnosed by ultrasound and severity of fibrosis was measured by non-invasive fibrosis markers such as the NAFLD fibrosis score (NFS).

Findings indicate that of the 11,154 participants, 34% had NAFLD, with 72% of these patients having a NFS that indicated lack of significant fibrosis (NFS less than -1.455) and 3% with advanced fibrosis (NFS greater than 0.676). NAFLD was not associated with higher mortality risk after a median of 15 years of follow-up.

Further analysis shows that mortality increases as fibrosis advances. In fact, patients likely to progress to advanced fibrosis had a 69% increase in mortality compared to those without fibrosis. Higher mortality in those with advanced fibrosis was largely due to cardiovascular causes, more than expected from conditions common in patients with NAFLD such as high blood pressure or high levels of cholesterol. "Our findings confirm that NAFLD patients without advanced fibrosis do not have higher mortality risk," concludes Dr. Kim. "Careful monitoring of disease progression in patients with NAFLD and fibrosis, along with interventions that reduce cardiovascular risk factors are warranted."


'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Related medicine news :

1. Record Attendance at the Accreditation for Cardiovascular Excellence, ACE, Exhibit Booth at ACC.13
2. ACE, the Accreditation for Cardiovascular Excellence, Cited as Effective Program for Restoring Hospital Reputation
3. Delgado Protocol Announces Adrenal DMG, An Amazing New Supplement Designed to Support the Immune, Circulatory and Cardiovascular Systems
4. Los Angeles Periodontist, Dr. Markzar, is Now Informing Patients about the Possible Connection between Gum Disease and Cardiovascular Disease
5. Tooth loss associated with cardiovascular risk factors in patients with chronic heart disease
6. ViVitro Labs Adds Real-Time Wear Tester to Their Line of Cardiovascular Device Testing Equipment
7. Cardiovascular risk may remain for treated Cushings disease patients
8. Mainz University Medical Center receives further DFG funding for cardiovascular research
9. The worlds premier cardiovascular congress goes to Amsterdam
10. Study shows heart calcium scan predictive of diabetes-related death from cardiovascular disease
11. High hormone levels put young black males at risk for cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... ... ... in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” is ... works in a daycare and looks for inspiration in the local coffee shop as ... Seymour’s new book is an adventure of love and secrets. , After ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Knowledge is God’s ... guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene ... novels, and poetry collections. , “I have been writing since high school and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “God's Miracle Man: ... All Odds” is the creation of published author, Keith C. A. Tucker, son of ... Christian Fellowship World Outreach pastured by Reverend Mark Hardy , “While sitting up in ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , January 19, 2017 According ... market for cryotherapy is set to witness a CAGR of 6.5% ... North America will continue to be the leading market ... ... Suppliers are emphasizing on ensuring affordable and adequate supply of ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... 2017 Pfizer joins Astex, ... Therapeutics Consortium   Major research investment ...   The Milner Therapeutics Institute ... as a partner to the Milner Therapeutics Consortium. Pfizer ... efficient transfer of materials between industry and academia and ...
Breaking Medicine Technology: